InsiderTrades.com logo
Has Trump Finally Gone Too Far?
From Insiders Exposed   |   Ad
Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.
Register For The Webinar To Discover

DXB Insider Trading

Insider Ownership Percentage: 23.47%
Insider Buying (Last 12 Months): A$77,110.80
Insider Selling (Last 12 Months): A$0.00

Dimerix Insider Trading History Chart

This chart shows the insider buying and selling history at Dimerix by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Dimerix Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 10/7/2021 12:12 PM ET

This chart shows the closing price history over time for DXB up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
$5k to $1.3m in just 3 trades
From Insiders Exposed   |   Ad
It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.
Register for the imminent briefing here.

Dimerix Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/25/2024Sonia PoliInsiderBuy167,202A$0.40A$66,880.80
3/27/2024Nina WebsterInsiderBuy33,000A$0.31A$10,230.00
See Full Table
Watch this before it gets removed
From Porter & Company   |   Ad
If you missed it, my emergency election broadcast is now available - but will be removed soon
Click here to watch it now.

SEC Filings (Institutional Ownership Changes) for Dimerix (ASX:DXB)

0.67% of Dimerix stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Dimerix logo
Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. The company develops DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; DMX-200 which is in phase 2 clinical trial for diabetic kidney disease; DMX-200 for ARDS associated with COVID-19; and DMX-700 for chronic obstructive pulmonary disease, as well as develops proprietary receptor- HIT assay technology. Dimerix Limited is headquartered in Fitzroy, Australia.
Read More on Dimerix

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

5.16%

Beta

0.53

Who are the company insiders with the largest holdings of Dimerix?

Dimerix's top insider shareholders include:
  1. Nina Webster (Insider)
  2. Sonia Poli (Insider)
Learn More about top insider investors at Dimerix.
Has Trump Finally Gone Too Far?
From Insiders Exposed   |   Ad
Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.
Register For The Webinar To Discover